Funding news
Synakis logo

Synakis Raises $2.6M in Pre-

Recently funded · $2.6M Pre-seedHospitals and Health CareCAView source

Get the full Synakis company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Toronto-based biotech Synakis, which develops biomaterial-based treatments for ocular diseases, has secured $2.6M in pre-seed funding. The capital will support the startup's ongoing work in this specialized field.

The investment was provided by Ontario’s Life Sciences Innovation Fund, backing Synakis's focus on creating new biomaterial-based therapies for various eye conditions.

Congratulations to Synakis on the successful close of an oversubscribed $2.6M pre-seed financing round to advance novel ocular therapies for retinal disease and glaucoma.

Ontario is strengthening its position as a global #LifeSciences hub, and it’s exciting to see companies like Synakis translating breakthrough research into real-world patient impact. Through Ontario’s Life Sciences Innovation Fund (#LSIF), we’re proud to support high-potential ventures working to address critical unmet healthcare needs across the province. Read more. 👇

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other Canada companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Pre-seed rounds

Companies that recently closed a Pre-seed round.

#CompanyAmount
1
shatterdome energy logo

shatterdome energy

India

$3.5M
2
Meta Fashion logo

Meta Fashion

India

$400.0K
3
AVIAN logo

AVIAN

Switzerland

$2.6M
4
EvoTouch logo

EvoTouch

$332.8K
5
StitcherAI logo

StitcherAI

United States

$3.0M